Earth Science Tech (ETST)

What Moves the Stock

1. 01Regulatory developments affecting cannabinoid-based pharmaceuticals and CBD product classifications
2. 02New product launches or clinical trial results for proprietary formulations
3. 03Distribution agreements with major retailers or pharmacy chains
4. 04Quarterly revenue growth rates and gross margin sustainability as the company scales
5. 05Changes in consumer acceptance and market penetration of cannabinoid-based wellness products
6. 06Cannabinoid-based pharmaceutical products and formulations (estimated 60-70% of revenue)
7. 07Dietary supplements and nutraceutical products (estimated 20-30% of revenue)
8. 08Potential licensing or distribution agreements (estimated 10% of revenue)

ETST Chart

My Notes

• momentum/speculative - The combination of explosive 300%+ net income growth, micro-cap size…
• Rising interest rates create multiple headwinds: (1) Higher discount rates compress valuation multiples for high-growth…
• Watch on earnings: Absolute quarterly revenue figures to assess scale and sustainability beyond percentage growth rates, Operating cash flow generation and cash burn rate to evaluate financing needs, Gross margin trends as production volumes increase and competitive pressures emerge.